115 MPs of European Parliament back India's Covid vaccine proposal at WTO

Goyal says India's proposal getting widespread support

vaccine, vaccination, coronavirus, covid
Earlier, European Commission and European Council had opposed the proposal
Nikunj OhriIndivjal Dhasmana New Delhi
3 min read Last Updated : Feb 25 2021 | 11:33 PM IST
India's proposal at the World Trade Organisation (WTO) to waive provisions of Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) has drawn support from 115 members of European Parliament.

Earlier, European Commission and European Council had opposed the proposal. In a declaration, these members said that they urge the European Commission and the European Council to review their stand.

Earlier in the day, Commerce and Industry Minister Piyush Goyal had said that India’s proposal at the WTO is getting support from other nations.

India along with South Africa had introduced a proposal in October 2020 for waiving the intellectual property rights regime so that more countries get equitable access to medicines, Goyal said at the International Conference on Pharmaceuticals and Medical organised by industry body FICCI.

“We now have 57 WTO members supporting us. We have many African countries already on board. The developed world is under pressure because on one hand, they talk about supporting each other and multilateral fight against Covid pandemic, but on the other hand, they're looking at protecting the interests of a few companies only in terms of innovation costs or R&D,” Goyal said.

The world is fighting a pandemic which could potentially cost $9 trillion to the global economy, and many sectors such as tourism, travel and hospitality have collapsed, Goyal said.
 
India has seen a golden period for health care in the last few years, and the industry should strive to make the next ten years “the decade of India” where the entire world should be following Indian standards, Goyal said.

Between 2021 to 2030, the entire world should be driven by Indian quality standards, regulatory processes, and manufacturing practices, he said. The industry should take it upon itself as a mission that this is going to be the defining decade, both for the pharma industry, and for the country, Goyal said.
 
Goyal said the world today needs CURE that will come out of Cost-effective Universal solutions through Research and Enterprise. “If we take it upon ourselves that India is going to cure the world, I see no limitations in our ability to aspire to become a world dominant leader in the field of medtech, pharmaceuticals, medical devices, and health care providers,” he said

The country would always be indebted to the Indian pharma industry, often called the pharmacy of the world, for its contribution through the Covid-19 pandemic, Goyal said.

The three V's that the pharma industry has provided to the world, and India-ventilators, vaccines, and the V-shaped recovery in India’s economy, are reflective of the industry’s strength.

Pharma industry has relatively been insulated during the Covid pandemic, and “I'm sure the industry will show a big heart across the world, support the TRIPS waiver that India has proposed at the WTO, so that the entire world can come out of the Covid pandemic much faster, and bring back the V-shaped recovery to the entire world,” he said.
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Piyush GoyalEuropean ParliamentCoronavirus VaccineWorld Trade Organization WTOIPR policyIntellectual Property RightFICCI

Next Story